2.21
price up icon0.00%   0.00
 
loading
Soligenix Inc stock is traded at $2.21, with a volume of 10,819. It is up +0.00% in the last 24 hours and down -4.33% over the past month.
See More
Previous Close:
$2.21
Open:
$2.185
24h Volume:
10,819
Relative Volume:
0.05
Market Cap:
$6.97M
Revenue:
$960.60K
Net Income/Loss:
$-7.10M
P/E Ratio:
-0.2923
EPS:
-7.56
Net Cash Flow:
$-8.00M
1W Performance:
-5.15%
1M Performance:
-4.33%
6M Performance:
-54.62%
1Y Performance:
-74.42%
1-Day Range:
Value
$2.17
$2.24
1-Week Range:
Value
$2.10
$2.31
52-Week Range:
Value
$1.8301
$14.92

Soligenix Inc Stock (SNGX) Company Profile

Name
Name
Soligenix Inc
Name
Phone
609-538-8200
Name
Address
29 EMMONS DRIVE, PRINCETON
Name
Employee
0
Name
Twitter
@Soligenix_Inc
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
SNGX's Discussions on Twitter

Compare SNGX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
SNGX
Soligenix Inc
2.21 6.97M 960.60K -7.10M -8.00M -7.56
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
483.49 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
625.60 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
583.62 35.60B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
266.83 34.53B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
274.78 29.15B 3.81B -644.79M -669.77M -6.24

Soligenix Inc Stock (SNGX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-28-20 Downgrade Dawson James Buy → Neutral
Jan-31-18 Downgrade H.C. Wainwright Buy → Neutral
Aug-14-17 Reiterated Maxim Group Buy
Jul-17-17 Initiated H.C. Wainwright Buy

Soligenix Inc Stock (SNGX) Latest News

pulisher
Mar 29, 2025

Zacks Small Cap Decreases Earnings Estimates for Soligenix - Defense World

Mar 29, 2025
pulisher
Mar 28, 2025

Q1 Earnings Forecast for Soligenix Issued By Zacks Small Cap - Defense World

Mar 28, 2025
pulisher
Mar 26, 2025

SNGX: Preclinical Data Shows CiVax™ Booster Induces Broad Protection Against COVID-19… - Yahoo Finance

Mar 26, 2025
pulisher
Mar 25, 2025

CiVax booster shows broad COVID-19 variant protection By Investing.com - Investing.com South Africa

Mar 25, 2025
pulisher
Mar 25, 2025

IBN Initiates Coverage of Soligenix Inc. - GlobeNewswire

Mar 25, 2025
pulisher
Mar 25, 2025

First National Financial Corporation to Host First Quarter Earnings Call on April 30, 2025 - The Globe and Mail

Mar 25, 2025
pulisher
Mar 25, 2025

CiVax booster shows broad COVID-19 variant protection - Investing.com

Mar 25, 2025
pulisher
Mar 25, 2025

Revolutionary Heat-Stable COVID Booster Outperforms mRNA Vaccines Against Variants - Stock Titan

Mar 25, 2025
pulisher
Mar 21, 2025

Soligenix Inc. (SNGX) reports earnings - Quartz

Mar 21, 2025
pulisher
Mar 21, 2025

SOLIGENIX, INC. SEC 10-K Report - TradingView

Mar 21, 2025
pulisher
Mar 21, 2025

Soligenix Trumps Year-End Financials - Baystreet.ca

Mar 21, 2025
pulisher
Mar 21, 2025

Soligenix reports progress and 2024 financials By Investing.com - Investing.com Australia

Mar 21, 2025
pulisher
Mar 21, 2025

Soligenix reports progress and 2024 financials - Investing.com India

Mar 21, 2025
pulisher
Mar 21, 2025

Soligenix Announces Recent Accomplishments and Year End 2024 Financial Results - Quantisnow

Mar 21, 2025
pulisher
Mar 21, 2025

Soligenix Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 21, 2025
pulisher
Mar 21, 2025

Soligenix Financial Results Reveal Widening Losses While Clinical Pipeline Expands - StockTitan

Mar 21, 2025
pulisher
Mar 19, 2025

Why Soligenix (NASDAQ: SNGX) Is ‘One to Watch’ - The Globe and Mail

Mar 19, 2025
pulisher
Mar 14, 2025

Soligenix Inc expected to post a loss of 95 cents a shareEarnings Preview - TradingView

Mar 14, 2025
pulisher
Mar 14, 2025

Soligenix (SNGX) Projected to Post Earnings on Friday - Defense World

Mar 14, 2025
pulisher
Mar 13, 2025

Soligenix (NASDAQ: SNGX) Is ‘One to Watch’ - The Globe and Mail

Mar 13, 2025
pulisher
Mar 13, 2025

Soligenix Inc. (NASDAQ: SNGX) Is ‘One to Watch’ - Financial Content

Mar 13, 2025
pulisher
Mar 11, 2025

Soligenix (SNGX) Projected to Post Earnings on Thursday - Armenian Reporter

Mar 11, 2025
pulisher
Mar 09, 2025

AllPennyStocks.com News: A Steady Stream of News and Developments Pushes Soligenix Near 52 Week High - ACCESS Newswire

Mar 09, 2025
pulisher
Mar 08, 2025

Soligenix, Inc. (NASDAQ:SNGX) Sees Large Decrease in Short Interest - Defense World

Mar 08, 2025
pulisher
Mar 06, 2025

HyBryte™ Treatment Studies Presented at Two Medical Conferences in March - Yahoo Finance

Mar 06, 2025
pulisher
Mar 06, 2025

Soligenix (SNGX) Projected to Post Quarterly Earnings on Thursday - Defense World

Mar 06, 2025
pulisher
Mar 06, 2025

BiomednewsbreaksSoligenix Inc. (SNGX) To Present Hybrytetm And SGX302 Data At Dermatology Conferences - MENAFN.COM

Mar 06, 2025
pulisher
Feb 28, 2025

Soligenix and American Resources Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 26, 2025

Soligenix Aims To Push The Boundaries In Treating Rare Diseases - The Globe and Mail

Feb 26, 2025
pulisher
Feb 25, 2025

Soligenix Advances Innovative Treatments for Rare Diseases - citybuzz -

Feb 25, 2025
pulisher
Feb 24, 2025

TALTZ’s Rapid Market Ascent Reflects its Unparalleled Ability to Transform the Treatment Landscape for Autoimmune Diseases | DelveInsight - GlobeNewswire Inc.

Feb 24, 2025
pulisher
Feb 21, 2025

Soligenix's Leadership Aims To Drive Growth In Rare Disease Markets In 2025 And 2026 - The Globe and Mail

Feb 21, 2025
pulisher
Feb 21, 2025

Silicon Valley - Financial Content

Feb 21, 2025
pulisher
Feb 20, 2025

SoundHound AI Stock at a Crossroads—Is a Bottom in Sight? - The Globe and Mail

Feb 20, 2025
pulisher
Feb 12, 2025

Soligenix settles debt with Pontifax lenders - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

Soligenix, Inc. Repays and Terminates Loan Agreement with Pontifax Medison FinanceOn February 5, 2025, Soligenix, Inc. (NASDAQ:SNGX) announced in an SEC Filing the full repayment and termination of all outstanding obligations under the Loan and Se - Defense World

Feb 12, 2025
pulisher
Feb 10, 2025

Soligenix Repays Loan, Boosting Financial Flexibility - TipRanks

Feb 10, 2025
pulisher
Feb 04, 2025

Soligenix on Way to Bio Conference in NYC - Baystreet.ca

Feb 04, 2025
pulisher
Feb 04, 2025

Rare Disease Pioneer Soligenix Takes Center Stage at Major Biotech Investor Summit - StockTitan

Feb 04, 2025
pulisher
Jan 30, 2025

Symbol Lookup - GuruFocus.com

Jan 30, 2025
pulisher
Jan 29, 2025

SPI Energy and Soligenix Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV - ACCESS Newswire

Jan 29, 2025
pulisher
Jan 26, 2025

Soligenix and Sharps Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire

Jan 26, 2025
pulisher
Jan 25, 2025

Soligenix (NASDAQ:SNGX) & Rhythm Pharmaceuticals (NASDAQ:RYTM) Head to Head Contrast - Defense World

Jan 25, 2025
pulisher
Jan 23, 2025

Soligenix (SNGX) Stock Price, News & Analysis - MarketBeat

Jan 23, 2025
pulisher
Jan 22, 2025

Soligenix (NASDAQ: $SNGX) Unveils Two-Pronged Approach To Tackle Rare Diseases & Unmet Medical Needs - MSN

Jan 22, 2025
pulisher
Jan 16, 2025

Soligenix to Present at Upcoming Investor Conferences - PR Newswire

Jan 16, 2025
pulisher
Jan 16, 2025

Soligenix to Present at Two Major Investor Conferences in January 2024 - Stock Titan

Jan 16, 2025

Soligenix Inc Stock (SNGX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$73.44
price up icon 2.00%
$68.32
price up icon 0.56%
$31.28
price up icon 0.35%
$20.46
price up icon 8.83%
$93.32
price up icon 3.36%
biotechnology ONC
$274.78
price up icon 1.38%
Cap:     |  Volume (24h):